Carbon Nanotubes in the Diagnosis and Treatment of Malignant Melanoma

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)

Volume 17, 14 Issues, 2017

Download PDF Flyer

Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 27th of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
Université Clermont Auvergne

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.722
5 - Year: 2.849

Carbon Nanotubes in the Diagnosis and Treatment of Malignant Melanoma

Anti-Cancer Agents in Medicinal Chemistry, 13(1): 171-185.

Author(s): Naghmeh Naderi, Seyed Y. Madani, Elaine Ferguson, Afshin Mosahebi and Alexander M Seifalian.

Affiliation: Nanotechnology & Regenerative Medicine, University College London.


The potential role of carbon nanotubes (CNTs) in the diagnosis and treatment of malignant melanoma (MM) is still an emerging area of research. To date, there is strong evidence for the efficiency of CNTs in this therapeutic area, despite their unique physical, mechanical and biological properties. In this review, the application of CNTs in cancer diagnostics and treatment is reviewed, and consideration is given to the toxicity issues associated with their use.


Carbon nanotube, Cancer, Diagnostic, Treatment, Nanotechnology, Malignant, Melanoma, Drug deliver, Toxicology, Nanotoxicity, Thermal effect.

Download Free Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 13
Issue Number: 1
First Page: 171
Last Page: 185
Page Count: 15
DOI: 10.2174/1871520611307010171

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science